Latest News and Press Releases
Want to stay updated on the latest news?
-
TULSA, OK, June 13, 2016 (GLOBE NEWSWIRE) -- Laredo Petroleum, Inc. (NYSE:LPI) (“Laredo” or the “Company”), will host an investor meeting today in Midland, TX to update current activities,...
-
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., June 13, 2016 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 13, 2016) - The following issues have been halted by IIROC / L'OCRCVM a suspendu la negociation des titres suivants: ...
-
LOS ANGELES, June 13, 2016 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ:PFBC), an independent commercial bank, today announced the completion of a private placement of $62.5 million in principal...
-
NEWARK, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in aesthetic and therapeutic...
-
BUFFALO, N.Y. and SAN FRANCISCO, June 13, 2016 (GLOBE NEWSWIRE) -- Synacor, Inc. (Nasdaq:SYNC), the trusted multiscreen technology and monetization company for video, internet and...
-
WALTHAM, Mass., June 13, 2016 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell shares of...
-
BEIJING, June 13, 2016 (GLOBE NEWSWIRE) -- Wowo Limited (the “Company”) (NASDAQ:JMU), a leading B2B online e-commerce platform that provides integrated services to suppliers and customers in the...
-
Paratek to Present Omadacycline Microbiologic, Pharmacokinetic and Clinical Data at ASM Microbe 2016
- Biofilm, post-antibiotic effects, microbiologic surveillance and omadacycline in vitro activity against select pathogens to be presented - Clinical PK and Modelling Strategies for omadacycline to...
-
Ability to Use Clinically Validated hpv testsFive-Year Stability of GTL001 Drug Product PARIS and TOULOUSE, France, June 13, 2016 (GLOBE NEWSWIRE) -- Genticel (Euronext Paris & Brussels:...